Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2011

Open Access 01-12-2011 | Research

Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in parkinson's disease

Authors: Regina Rendas-Baum, Philip O Buck, Michelle K White, Jane Castelli-Haley

Published in: Health and Quality of Life Outcomes | Issue 1/2011

Login to get access

Abstract

Background

To identify key non-motor symptoms of Parkinson's disease (PD) to include in a daily diary assessment for off-time, revise the Scales for Outcomes of Parkinson's disease Diary Card (SCOPA-DC) to include these non-motor symptoms, and investigate the validity, reliability and predictive utility of the Revised SCOPA-DC in a U.S. population.

Methods

A convenience sample was used to recruit four focus groups of PD patients. Based on findings from focus groups, the SCOPA-DC was revised and administered to a sample of 101 PD patients. Confirmatory factor analysis was conducted to test the domain structure of the Revised SCOPA-DC. The reliability, convergent and discriminant validity, and ability to predict off-time of the Revised SCOPA-DC were then assessed.

Results

Based on input from PD patients, the Revised SCOPA-DC included several format changes and the addition of non-motor symptoms. The Revised SCOPA-DC was best represented by a three-factor structure: Mobility, Physical Functioning and Psychological Functioning. Correlations between the Revised SCOPA-DC and other Health-Related Quality of Life scores were supportive of convergent validity. Known-groups validity analyses indicated that scores on the Revised SCOPA-DC were lower among patients who reported experiencing off-time when compared to those without off-time. The three subscales had satisfactory predictive utility, correctly predicting off-time slightly over two-thirds of the time.

Conclusions

These findings provide evidence of content validity of the Revised SCOPA-DC and suggest that a three-factor structure is an appropriate model that provides reliable and valid scores to assess symptom severity among PD patients with symptom fluctuations in the U.S.
Appendix
Available only for authorised users
Literature
1.
go back to reference de Lau LM, Breteler MM: Epidemiology of Parkinson's disease. Lancet Neurol 2006,5(6):525–535. 10.1016/S1474-4422(06)70471-9PubMedCrossRef de Lau LM, Breteler MM: Epidemiology of Parkinson's disease. Lancet Neurol 2006,5(6):525–535. 10.1016/S1474-4422(06)70471-9PubMedCrossRef
2.
go back to reference Nussbaum RL, Ellis CE: Alzheimer's disease and Parkinson's disease. N Engl J Med 2003,348(14):1356–1364. 10.1056/NEJM2003ra020003PubMedCrossRef Nussbaum RL, Ellis CE: Alzheimer's disease and Parkinson's disease. N Engl J Med 2003,348(14):1356–1364. 10.1056/NEJM2003ra020003PubMedCrossRef
3.
4.
go back to reference Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW: International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006,21(7):916–923. 10.1002/mds.20844PubMedCrossRef Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW: International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006,21(7):916–923. 10.1002/mds.20844PubMedCrossRef
5.
go back to reference Cheon SM, Ha MS, Park MJ, Kim JW: Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord 2008,14(4):286–290. 10.1016/j.parkreldis.2007.09.002PubMedCrossRef Cheon SM, Ha MS, Park MJ, Kim JW: Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord 2008,14(4):286–290. 10.1016/j.parkreldis.2007.09.002PubMedCrossRef
6.
go back to reference Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR: Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007,22(11):1623–1629. 10.1002/mds.21586PubMedCrossRef Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR: Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007,22(11):1623–1629. 10.1002/mds.21586PubMedCrossRef
7.
go back to reference Simuni T, Sethi K: Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008,64(Suppl 2):S65-S80.PubMed Simuni T, Sethi K: Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008,64(Suppl 2):S65-S80.PubMed
8.
go back to reference Snyder CH, Adler CH: The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms. J Am Acad Nurse Pract 2007,19(4):179–197. 10.1111/j.1745-7599.2007.00211.xPubMedCrossRef Snyder CH, Adler CH: The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms. J Am Acad Nurse Pract 2007,19(4):179–197. 10.1111/j.1745-7599.2007.00211.xPubMedCrossRef
9.
go back to reference Zesiewicz TA, Sullivan KL, Hauser RA: Nonmotor symptoms of Parkinson's disease. Expert Rev Neurother 2006,6(12):1811–1822. 10.1586/14737175.6.12.1811PubMedCrossRef Zesiewicz TA, Sullivan KL, Hauser RA: Nonmotor symptoms of Parkinson's disease. Expert Rev Neurother 2006,6(12):1811–1822. 10.1586/14737175.6.12.1811PubMedCrossRef
10.
go back to reference Gallagher DA, Schrag A: Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease. CNS Drugs 2008,22(7):563–586. 10.2165/00023210-200822070-00003PubMedCrossRef Gallagher DA, Schrag A: Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease. CNS Drugs 2008,22(7):563–586. 10.2165/00023210-200822070-00003PubMedCrossRef
11.
go back to reference Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ: Clinical features and comorbidity of mood fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002,14(4):438–442. 10.1176/appi.neuropsych.14.4.438PubMedCrossRef Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ: Clinical features and comorbidity of mood fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002,14(4):438–442. 10.1176/appi.neuropsych.14.4.438PubMedCrossRef
12.
go back to reference Buck PO, Trautman H, Clark J: Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations. International Journal of Neuroscience 2010,120(8):523–530. 10.3109/00207454.2010.489725PubMedCrossRef Buck PO, Trautman H, Clark J: Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations. International Journal of Neuroscience 2010,120(8):523–530. 10.3109/00207454.2010.489725PubMedCrossRef
13.
go back to reference Quinn NP: Classification of fluctuations in patients with Parkinson's disease. Neurology 1998,51(2 Suppl 2):S25-S29.PubMedCrossRef Quinn NP: Classification of fluctuations in patients with Parkinson's disease. Neurology 1998,51(2 Suppl 2):S25-S29.PubMedCrossRef
14.
go back to reference Hou JG, Lai EC: Overview of Parkinson's disease: clinical features, diagnosis, and management. In Neurorehabilitation in Parkinson's Disease: An Evidence Based Treatment Model. Edited by: Trail M, Protas EJ, Lai EC. NJ: Slack Incorporated; 2008:1–40. Hou JG, Lai EC: Overview of Parkinson's disease: clinical features, diagnosis, and management. In Neurorehabilitation in Parkinson's Disease: An Evidence Based Treatment Model. Edited by: Trail M, Protas EJ, Lai EC. NJ: Slack Incorporated; 2008:1–40.
15.
go back to reference Brooks DJ, Agid Y, Eggert K, Widner H, Ostergaard K, Holopainen A: Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. Eur Neurol 2005,53(4):197–202. 10.1159/000086479PubMedCrossRef Brooks DJ, Agid Y, Eggert K, Widner H, Ostergaard K, Holopainen A: Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. Eur Neurol 2005,53(4):197–202. 10.1159/000086479PubMedCrossRef
16.
go back to reference Trail M, Protas EJ, Lai EC: Neurorehabilitation in Parkinson's Disease: An Evidence Based Treatment Model. NJ: Slack Incorporated; 2008. Trail M, Protas EJ, Lai EC: Neurorehabilitation in Parkinson's Disease: An Evidence Based Treatment Model. NJ: Slack Incorporated; 2008.
17.
go back to reference Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E: End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clin Neuropharmacol 2006,29(9):312–321.PubMedCrossRef Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E: End-of-dose wearing off in Parkinson disease: a 9-question survey assessment. Clin Neuropharmacol 2006,29(9):312–321.PubMedCrossRef
18.
go back to reference Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, MacPhee G, MacMahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH: The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 2007,22(13):1901–1911. 10.1002/mds.21596PubMedCrossRef Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, MacPhee G, MacMahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH: The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 2007,22(13):1901–1911. 10.1002/mds.21596PubMedCrossRef
19.
go back to reference Pursiainen V, Haapaniemi TH, Korpelainen JT, Sotaniemi KA, Myllyla VV: Sweating in Parkinsonian patients with wearing-off. Mov Disord 2007,22(6):828–832. 10.1002/mds.21422PubMedCrossRef Pursiainen V, Haapaniemi TH, Korpelainen JT, Sotaniemi KA, Myllyla VV: Sweating in Parkinsonian patients with wearing-off. Mov Disord 2007,22(6):828–832. 10.1002/mds.21422PubMedCrossRef
20.
go back to reference Witjas T, Kaphan E, Regis J, Jouve E, Cherif AA, Peragut JC, Azulay JP: Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007,22(12):1729–1734. 10.1002/mds.21602PubMedCrossRef Witjas T, Kaphan E, Regis J, Jouve E, Cherif AA, Peragut JC, Azulay JP: Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007,22(12):1729–1734. 10.1002/mds.21602PubMedCrossRef
21.
go back to reference Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Cherif AA: Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002,59(3):408–413.PubMedCrossRef Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Cherif AA: Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002,59(3):408–413.PubMedCrossRef
22.
go back to reference Marinus J, Visser M, Stiggelbout AM, Rabey JM, Bonuccelli U, Kraus PH, van Hilten JJ: Activity-based diary for Parkinson's disease. Clin Neuropharmacol 2002,25(1):43–50. 10.1097/00002826-200201000-00008PubMedCrossRef Marinus J, Visser M, Stiggelbout AM, Rabey JM, Bonuccelli U, Kraus PH, van Hilten JJ: Activity-based diary for Parkinson's disease. Clin Neuropharmacol 2002,25(1):43–50. 10.1097/00002826-200201000-00008PubMedCrossRef
23.
go back to reference Strauss A, Corbin J: Grounded Theory Methodology: an overview. In Strategies of Qualitative Inquiry. Edited by: Denzin N, Lincoln Y. London: Sage; 2003:273–285. Strauss A, Corbin J: Grounded Theory Methodology: an overview. In Strategies of Qualitative Inquiry. Edited by: Denzin N, Lincoln Y. London: Sage; 2003:273–285.
25.
go back to reference Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B: How to Score Version 2 of the SF-12 ® Health Survey (With a Supplement Documenting Version 1). RI: QualityMetric Incorporated; 2002. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B: How to Score Version 2 of the SF-12 ® Health Survey (With a Supplement Documenting Version 1). RI: QualityMetric Incorporated; 2002.
26.
go back to reference Kosinski M, Bjorner JB: Evaluation of the validity of BDI scores estimated from the SF-36 mental health scale. Quality of Life Research 2009, 1416: A24. Kosinski M, Bjorner JB: Evaluation of the validity of BDI scores estimated from the SF-36 mental health scale. Quality of Life Research 2009, 1416: A24.
27.
go back to reference Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N: The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psycho Health 1997, 12: 805–814. 10.1080/08870449708406741CrossRef Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N: The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psycho Health 1997, 12: 805–814. 10.1080/08870449708406741CrossRef
28.
go back to reference Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murck H, Meng X: The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Parkinsonism Relat Disord 2008,14(3):205–212. 10.1016/j.parkreldis.2007.07.013PubMedCrossRef Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murck H, Meng X: The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Parkinsonism Relat Disord 2008,14(3):205–212. 10.1016/j.parkreldis.2007.07.013PubMedCrossRef
29.
go back to reference Burman PA: A comparative study of ordinary cross validation, k fold cross validation and repeated learning tested methods. Biometrika 1989, 503–514. Burman PA: A comparative study of ordinary cross validation, k fold cross validation and repeated learning tested methods. Biometrika 1989, 503–514.
30.
go back to reference Muthen B: Tobit factor analysis. British Journal of Mathematical and Statistical Psychology 1989, 42: 241–250. 10.1111/j.2044-8317.1989.tb00913.xCrossRef Muthen B: Tobit factor analysis. British Journal of Mathematical and Statistical Psychology 1989, 42: 241–250. 10.1111/j.2044-8317.1989.tb00913.xCrossRef
31.
go back to reference Hu L, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling 1999, 6: 1–55.CrossRef Hu L, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling 1999, 6: 1–55.CrossRef
32.
go back to reference Brown T: Confirmatory Factor Analysis for Applied Research. New York: The Guilford Press; 2006. Brown T: Confirmatory Factor Analysis for Applied Research. New York: The Guilford Press; 2006.
33.
go back to reference Hendrickson AE, White PO: Promax: A quick method for rotation to oblique simple structure. British Journal of Mathematical and Statistical Psychology 1964, 17: 65–70.CrossRef Hendrickson AE, White PO: Promax: A quick method for rotation to oblique simple structure. British Journal of Mathematical and Statistical Psychology 1964, 17: 65–70.CrossRef
34.
go back to reference Muthen LD, Muthen BO: MPlus User's Guide. 5th edition. CA: Muthen & Muthen; 2007. Muthen LD, Muthen BO: MPlus User's Guide. 5th edition. CA: Muthen & Muthen; 2007.
35.
go back to reference Nunnally JC, Bernstein IH: Psychometric Theory. 3rd edition. New York: McGraw-Hill; 1994. Nunnally JC, Bernstein IH: Psychometric Theory. 3rd edition. New York: McGraw-Hill; 1994.
36.
go back to reference Clark LA, Watson D: Constructing validity: Basic issues in objective scale development. Psychological Assessment 1995,7(3):309–319.CrossRef Clark LA, Watson D: Constructing validity: Basic issues in objective scale development. Psychological Assessment 1995,7(3):309–319.CrossRef
37.
go back to reference Kerlinger F: Foundations of Behavioral Research. New York: Holt, Rinehart & Winston; 1973. Kerlinger F: Foundations of Behavioral Research. New York: Holt, Rinehart & Winston; 1973.
38.
go back to reference Diggle P, Heagerty P, Liang K: Analysis of Longitudinal Data. second edition. Oxford: University Press; 2002. Diggle P, Heagerty P, Liang K: Analysis of Longitudinal Data. second edition. Oxford: University Press; 2002.
39.
go back to reference Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ: A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol 2008,255(10):1580–1587. 10.1007/s00415-008-0994-4PubMedCrossRef Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ: A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol 2008,255(10):1580–1587. 10.1007/s00415-008-0994-4PubMedCrossRef
40.
go back to reference Visser M, Verbaan D, van Rooden S, Marinus J, van Hilten J, Stiggelbout A: A Longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health 2009,12(2):392–396. 10.1111/j.1524-4733.2008.00430.xPubMedCrossRef Visser M, Verbaan D, van Rooden S, Marinus J, van Hilten J, Stiggelbout A: A Longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health 2009,12(2):392–396. 10.1111/j.1524-4733.2008.00430.xPubMedCrossRef
41.
go back to reference Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G: Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008,23(10):1420–1427. 10.1002/mds.22121PubMedCrossRef Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G: Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008,23(10):1420–1427. 10.1002/mds.22121PubMedCrossRef
42.
go back to reference Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Kohne-Volland R, Dodel RC: Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism Relat Disord 2007,13(2):108–114. 10.1016/j.parkreldis.2006.07.009PubMedCrossRef Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Kohne-Volland R, Dodel RC: Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism Relat Disord 2007,13(2):108–114. 10.1016/j.parkreldis.2006.07.009PubMedCrossRef
43.
go back to reference Jackson DL: Sample Size and number of parameter estimates in Maximum Likelihood Conformatory Factor Analysis: a Monte Carlo investigation. Structural Equation Modeling 2001,8(2):205–223. 10.1207/S15328007SEM0802_3CrossRef Jackson DL: Sample Size and number of parameter estimates in Maximum Likelihood Conformatory Factor Analysis: a Monte Carlo investigation. Structural Equation Modeling 2001,8(2):205–223. 10.1207/S15328007SEM0802_3CrossRef
44.
45.
go back to reference Lee MA, Walker RW, Hildreth AJ, Prentice WM: Individualized assessment of quality of life in idiopathic Parkinson's disease. Mov Disord 2006,21(11):1929–1934. 10.1002/mds.21099PubMedCrossRef Lee MA, Walker RW, Hildreth AJ, Prentice WM: Individualized assessment of quality of life in idiopathic Parkinson's disease. Mov Disord 2006,21(11):1929–1934. 10.1002/mds.21099PubMedCrossRef
46.
go back to reference Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N: Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008,23(15):2129–2170. 10.1002/mds.22340PubMedCrossRef Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N: Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008,23(15):2129–2170. 10.1002/mds.22340PubMedCrossRef
Metadata
Title
Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in parkinson's disease
Authors
Regina Rendas-Baum
Philip O Buck
Michelle K White
Jane Castelli-Haley
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2011
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-9-69

Other articles of this Issue 1/2011

Health and Quality of Life Outcomes 1/2011 Go to the issue